| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Tuesday, January 15, 2019 While the high cost of living in San Francisco has famously grabbed headlines, the costs of simply meeting there, even for a few days, are becoming untenable for some. |
|
|
Top Stories Of The Week Friday, January 11, 2019 The dealing has just begun. Often, M&A that took shape at the J.P. Morgan Healthcare Conference materializes later in the year, and some recent buzz puts Pfizer and Biogen at the center of potential takeovers. Monday, January 14, 2019 The changes and departures keep coming from AstraZeneca. Bloomberg reports that Sean Bohen, CMO and EVP of global medicines development, is out the door, following closely in the footsteps of Bahija Jallal, former head of its biologics arm MedImmune, as well as portfolio strategy chief Mark Mallon. Tuesday, January 15, 2019 Goodbye, goodies. The International Federation of Pharmaceutical Manufacturers and Associations updated its guidelines for 2019 to eliminate all gifts from prescription drug makers. Monday, January 14, 2019 In mouse models of metastatic breast cancer, a combination of GlaxoSmithKline’s diabetes drug Avandia and Novartis’ cancer treatment Mekinist transforms some tumor cells into harmless fat. Scientists at the University of Basel believe the two drugs could be combined with chemo to stop breast cancer from spreading. Wednesday, January 16, 2019 In a restructuring drive aimed at shrinking its payroll by 12,000 workers, Bayer is consolidating its corporate functions, beginning by shutting down a site near Pittsburgh, Pennsylvania. Wednesday, January 16, 2019 Fitbit and the National Institutes of Health (NIH) have launched a bring-your-own-device project for participants in the All of Us research program, with its first foray into wearables and digital health technology. Monday, January 14, 2019 Just months after a vaccine scandal made waves and undermined the public’s confidence in the country’s vaccine industry, 145 children in an eastern Chinese city were found to have received expired polio shots. Thursday, January 17, 2019 Pfizer has inked a deal with CytoReason to use the Tel Aviv-based drug discovery and development company’s cell-centered models of the immune system. Friday, January 11, 2019 Looking to streamline its biologics production, AstraZeneca is closing two plants in Colorado it bought separately from Amgen and is laying off all 210 workers stationed there. Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: DeciBio Consulting With the liquid biopsy market maturing and >80 companies still competing with liquid biopsy offerings, it is crucial for investors to be able to cut through the noise and identify the winners. Presented by: Aprecia Get ahead of looming challenges in the market that include both generic products and new branded drugs. Sponsored by: Oracle Health Sciences New infographic shows trends in clinical development and the impact on randomization and trial supply management technology (RTSM). Sponsored by: Veeva Reduce the effort to create submissions and track registrations with a move to unified RIM. Watch the on-demand webinar. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. |
